Troponin Leaks in Emergency Department Patients Presenting With Supraventricular Tachycardia (SVT)

NCT02810561 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2022-08-17

No results posted yet for this study

Summary

The goal of this study is twofold. First the investigators would like to determine the trajectory of troponin leaks; if it can be shown that the participants who have only minimal elevations of their repeat troponin universally decrease on the 3rd level then future patients may see significantly improved length of stay. Second, given conflicting results in the literature, the investigators would like to determine if elevated troponin levels correlate to later cardiovascular complications. These complications will be defined as Death, Myocardial Infarction, Cardiovascular intervention (such as coronary artery stenting or bypass). As the investigator is a single hospital system in this county it is uniquely positioned to be able to review this retrospectively.

Conditions

  • Supraventricular Tachycardia

Interventions

OTHER

No Intervention

No intervention was completed with this study.

Sponsors & Collaborators

  • Spectrum Health - Lakeland

    lead OTHER

Principal Investigators

  • Matthew Hysell, MD · Lakeland Health Emergency Department

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2016-07-31
Completion
2016-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02810561 on ClinicalTrials.gov